Antibiotics Biotechnology Centers for Disease Control Clinical Trials Coronavirus Coronavirus COVID-19 Healthcare IT News Infection Control Infectious Diseases rare diseases Research & Discovery Vaccines Vaccine development software shows promise in influenza effort, could help defeat coronavirus By Staff Reports 1 month ago A novel computer algorithm that could create a broadly reactive influenza vaccine for swine flu
Biotech Company News Biotechnology Coronavirus Coronavirus COVID-19 Infectious Diseases Pharmaceuticals Eureka Therapeutics Announces Successful Preclinical Results of InvisiMask™ Human Antibody Nasal Spray Against SARS-CoV-2 Infection By Staff Reports 4 months ago Newly published study reports InvisiMask™, a self-administered single-dose nasal spray, protects against SARS-CoV-2 infection for
Biotech Company News Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Infection Control Infectious Diseases rare diseases Vaccines Moderna’s virus vaccine shows overwhelming success in U.S. tests By Staff Reports 5 months ago Moderna said Monday its COVID-19 vaccine is proving highly effective in a major trial, a
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Infectious Diseases rare diseases Neuropilin-1 drives SARS-CoV-2 infectivity, finds breakthrough study By Staff Reports 6 months ago In a major breakthrough an international team of scientists, led by the University of Bristol,
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 NIH begins large clinical trial to test immune modulators for treatment of COVID-19 By Staff Reports 6 months ago The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 rare diseases Dried blood spot sampling offers an inexpensive way to widen access to antibody testing for COVID-19 By Staff Reports 6 months ago Using dried blood spot samples (DBS) is an accurate alternative to venous blood in detecting
Biotechnology Clinical Trials Coronavirus rare diseases Vaccines Investigational COVID-19 vaccine well-tolerated, generates immune response in older adults By Staff Reports 7 months ago A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown
Antibiotics Biotechnology Coronavirus Coronavirus COVID-19 Immunotherapies Infection Control Infectious Diseases Some Severe COVID-19 Cases Linked to Genetic Mutations or Antibodies that Attack the Body By Staff Reports 7 months ago People infected by the novel coronavirus can have symptoms that range from mild to deadly.
Biotechnology Cardiology Clinical Trials Coronavirus Coronavirus COVID-19 drug development Infectious Diseases rare diseases Potential new drug to mitigate SARS-CoV-2 infection consequences By Staff Reports 7 months ago Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Infectious Diseases rare diseases Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting By Staff Reports 7 months ago Eli Lilly and Company said proof of concept data from an interim analysis of the
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 rare diseases Vaccines Preclinical study of COVID-19 vaccine candidate shows potent T-cell responses By Staff Reports 8 months ago Preclinical studies of a COVID-19 vaccine candidate at the University of Alabama at Birmingham show
Biotechnology Coronavirus Coronavirus COVID-19 drug development UCI scientists get ‘initial hit’ in developing drug to treat COVID-19 By Staff Reports 8 months ago When the coronavirus pandemic hit, almost everyone at the University of California, Irvine – and
Biotechnology Coronavirus Coronavirus COVID-19 COVID-19: Patients Improve After Immune-Suppressant Treatment By Staff Reports 9 months ago Most patients hospitalized with COVID-19 (coronavirus) pneumonia experienced improvement after receiving a Food and Drug
Coronavirus COVID-19 Moderna’s Coronavirus Vaccine shows ‘Promising’ Safety and Immune response results in Published Phase 1 Study By Staff Reports 9 months ago A Covid-19 vaccine developed by the biotechnology company Moderna in partnership with the National Institutes of Health
Coronavirus Coronavirus COVID-19 rare diseases COVID-19 Fatality Risk Is Double Earlier Estimates By Staff Reports 10 months ago In one of the most robust studies of COVID-19 mortality risk in the United States,
Coronavirus COVID-19 How COVID-19 affects Pediatric Patients By Staff Reports 10 months ago New insights into the clinical and epidemiological characteristics of pediatric patients with coronavirus disease 2019
Biomarkers Coronavirus Immunotherapies Cancer Researchers Have a Head Start in Fight Against COVID-19 By Staff Reports 10 months ago Researchers at Roswell Park Comprehensive Cancer Center have been actively engaged in the effort to develop treatments or
Coronavirus Coronavirus COVID-19 How Communities Can Fight The Coronavirus Pandemic And PPE Shortage By Staff Reports 10 months ago As devastating as Coronavirus (COVID-19) is, there are some bright spots. Consider this: With healthcare
Coronavirus Coronavirus COVID-19 Positive Interim Phase 1 Data for Moderna’s mRNA Vaccine (mRNA-1273) Against Novel Coronavirus Announced By Staff Reports 11 months ago Moderna, Inc., unveiled news on their positive interim clinical data of mRNA-1273, the company’s vaccine
Coronavirus Coronavirus COVID-19 UC San Diego: Marrying molecular farming and advanced manufacturing to develop a COVID-19 vaccine By Staff Reports 12 months ago Nanoengineers at the University of California San Diego are working on a COVID-19 vaccine using